491 results on '"Schwendeman, Steven P"'
Search Results
2. Aqueous remote loading of model cationic peptides in uncapped poly(lactide-co-glycolide) microspheres for long-term controlled release
3. Mechanistic analysis of the photolytic decomposition of solid-state S-nitroso-N-acetylpenicillamine
4. In vitro degradation and erosion behavior of commercial PLGAs used for controlled drug delivery
5. Aqueous remote loading of setmelanotide in poly(lactic-co-glycolic acid) microspheres for long-term obesity treatment
6. Mechanistic evaluation of the initial burst release of leuprolide from spray-dried PLGA microspheres
7. In vitro performance of composition-equivalent PLGA microspheres encapsulating exenatide acetate by solvent evaporation
8. Influence of encapsulation variables on formation of leuprolide-loaded PLGA microspheres
9. Clinical translation of long-acting drug delivery formulations
10. Mapping in vivo microclimate pH distribution in exenatide-encapsulated PLGA microspheres
11. Minimizing the initial burst of octreotide acetate from glucose star PLGA microspheres prepared by the solvent evaporation method
12. Optimizing zinc-HisTag coordination remote loading of proteins in PLGA microspheres
13. Core-shell microneedle patch for six-month controlled-release contraceptive delivery
14. Characterization of commercial PLGAs by NMR spectroscopy
15. Development and characterization of composition-equivalent formulations to the Sandostatin LAR® by the solvent evaporation method
16. Efficient aqueous remote loading of peptides in poly(lactic-co-glycolic acid)
17. Coaxial electrospray of uniform polylactide core-shell microparticles for long-acting contraceptive
18. Immediate detachment of microneedles by interfacial fracture for sustained delivery of a contraceptive hormone in the skin
19. Microencapsulation of luteinizing hormone-releasing hormone agonist in poly (lactic-co-glycolic acid) microspheres by spray-drying
20. Feedback-controlled photolytic gas phase nitric oxide delivery from S-nitrosothiol-doped silicone rubber films
21. Predicting drug release kinetics from nanocarriers inside dialysis bags
22. Infliximab Biosimilars in the Age of Personalized Medicine
23. Stability of Proteins and Their Delivery from Biodegradable Polymer Microspheres
24. Correction to: Characterization of commercial PLGAs by NMR spectroscopy
25. Rapidly separable microneedle patch for the sustained release of a contraceptive
26. Data from Benefits of Multifaceted Chemopreventives in the Suppression of the Oral Squamous Cell Carcinoma (OSCC) Tumorigenic Phenotype
27. Supplemental Table S1 from Fenretinide Perturbs Focal Adhesion Kinase in Premalignant and Malignant Human Oral Keratinocytes. Fenretinide's Chemopreventive Mechanisms Include ECM Interactions
28. Supplemental Figure S1 from Fenretinide Perturbs Focal Adhesion Kinase in Premalignant and Malignant Human Oral Keratinocytes. Fenretinide's Chemopreventive Mechanisms Include ECM Interactions
29. Supplemental Figure 2 from Benefits of Multifaceted Chemopreventives in the Suppression of the Oral Squamous Cell Carcinoma (OSCC) Tumorigenic Phenotype
30. Data from Fenretinide Perturbs Focal Adhesion Kinase in Premalignant and Malignant Human Oral Keratinocytes. Fenretinide's Chemopreventive Mechanisms Include ECM Interactions
31. Supplemental Figure 4 from Benefits of Multifaceted Chemopreventives in the Suppression of the Oral Squamous Cell Carcinoma (OSCC) Tumorigenic Phenotype
32. Supplemental Figure 5 from Benefits of Multifaceted Chemopreventives in the Suppression of the Oral Squamous Cell Carcinoma (OSCC) Tumorigenic Phenotype
33. Supplemental Figure Legends from Benefits of Multifaceted Chemopreventives in the Suppression of the Oral Squamous Cell Carcinoma (OSCC) Tumorigenic Phenotype
34. Supplemental Figure 1 from Benefits of Multifaceted Chemopreventives in the Suppression of the Oral Squamous Cell Carcinoma (OSCC) Tumorigenic Phenotype
35. Supplemental Figure 2 from Fenretinide, Tocilizumab, and Reparixin Provide Multifaceted Disruption of Oral Squamous Cell Carcinoma Stem Cell Properties: Implications for Tertiary Chemoprevention
36. Supplemental Figure 5 from Fenretinide, Tocilizumab, and Reparixin Provide Multifaceted Disruption of Oral Squamous Cell Carcinoma Stem Cell Properties: Implications for Tertiary Chemoprevention
37. Supplemental Figure 3 from Benefits of Multifaceted Chemopreventives in the Suppression of the Oral Squamous Cell Carcinoma (OSCC) Tumorigenic Phenotype
38. Supplemental Figure 3 from Fenretinide, Tocilizumab, and Reparixin Provide Multifaceted Disruption of Oral Squamous Cell Carcinoma Stem Cell Properties: Implications for Tertiary Chemoprevention
39. Data from Fenretinide, Tocilizumab, and Reparixin Provide Multifaceted Disruption of Oral Squamous Cell Carcinoma Stem Cell Properties: Implications for Tertiary Chemoprevention
40. Supplemental Figure 1 from Fenretinide, Tocilizumab, and Reparixin Provide Multifaceted Disruption of Oral Squamous Cell Carcinoma Stem Cell Properties: Implications for Tertiary Chemoprevention
41. Supplemental Table 1 from Fenretinide, Tocilizumab, and Reparixin Provide Multifaceted Disruption of Oral Squamous Cell Carcinoma Stem Cell Properties: Implications for Tertiary Chemoprevention
42. Supplemental Figure 4 from Fenretinide, Tocilizumab, and Reparixin Provide Multifaceted Disruption of Oral Squamous Cell Carcinoma Stem Cell Properties: Implications for Tertiary Chemoprevention
43. Supplemental Table 2 from Fenretinide, Tocilizumab, and Reparixin Provide Multifaceted Disruption of Oral Squamous Cell Carcinoma Stem Cell Properties: Implications for Tertiary Chemoprevention
44. Mechanisms of in vivo release of triamcinolone acetonide from PLGA microspheres
45. Characterizing release mechanisms of leuprolide acetate-loaded PLGA microspheres for IVIVC development I: In vitro evaluation
46. Validation of a cage implant system for assessing in vivo performance of long-acting release microspheres
47. Biodegradable poly(lactic-co-glycolic acid) microspheres loaded with S-nitroso-N-acetyl-D-penicillamine for controlled nitric oxide delivery
48. Reverse Engineering the 1-Month Lupron Depot®
49. A biomimetic approach to active self-microencapsulation of proteins in PLGA
50. Injectable PLGA Systems for Delivery of Vaccine Antigens
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.